Press release
Progressive Ataxia And Weakness Disorders Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Point Of Sale (POS) Software Market Size
The market for progressive ataxia and weakness disorders has been expanding swiftly over recent years. It is projected to rise from $34.72 billion in 2024 to $38.67 billion in 2025, experiencing a compound annual growth rate (CAGR) of 11.4%. Factors such as heightened awareness and diagnostic rates, advancements in genetic research, increased government financial support, rising healthcare spending, and a surge in substance and alcohol abuse are all contributing to the historical growth.
The market for progressive ataxia and weakness disorders is anticipated to experience swift expansion in the upcoming years. It is projected to escalate to $58.68 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 11.0%. The forecasted growth is potentially due to the escalating frequency of neurological disorders, the increasing prevalence of chronic conditions, broader insurance coverage, and an aging society. Major projected trends for this period involve technological innovation, genetic analysis, gene-related therapy, individually tailored medicine, and the utilization of telemedicine.
What Factors Are Fueling Growth in the Progressive Ataxia And Weakness Disorders Market?
The burgeoning incidence of neurological diseases is anticipated to bolster the expansion of the progressive ataxia and weakness disorders market. Neurological disorders, which afflict the central and peripheral nervous systems encompassing the brain, spinal cord, cranial and peripheral nerves, autonomic nervous system, nerve roots, neuromuscular junction, and muscles, are on the rise due to factors such as an aging population, genetic influences, and infectious ailments. The role of progressive ataxia and weakness conditions is integral in neurology as they aid in diagnosing, treating, conducting research, and implementing patient care procedures aimed at enhancing the results and the quality of life of those dealing with these burdensome neurological diseases. For instance, data from the European Brain Council, a non-profit organization based in Belgium, in April 2022 indicated that the count of Europeans afflicted with dementia (a neurological disorder) stood at 10.5 million in 2022, a number that is expected to escalate to 18.7 million by 2050. Hence, the escalating incidence of neurological disorders is fuelling the growth of the progressive ataxia and weakness disorders market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18444&type=smp
Who Are the Major Industry Players Fueling Progressive Ataxia And Weakness Disorders Market Expansion?
Major companies operating in the progressive ataxia and weakness disorders market are Pfizer Inc., Merck & Co. Inc., Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Banner Health, Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Kissei Pharmaceutical Co. Ltd., Biohaven Pharmaceutical Holding Company Ltd., Design Therapeutics Inc., Anavex Life Sciences Corp., Larimar Therapeutics Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Capsida Biotherapeutics Inc., Retrotope Inc., Taysha Gene Therapies Inc., CRISPR Therapeutics AG
Which Key Developments Are Influencing the Progressive Ataxia And Weakness Disorders Market?
The primary organizations in the progressive ataxia and weakness disorders market are emphasizing on the development of groundbreaking products, like oral drugs for the treatment of Friedreich's ataxia in adults and adolescents above 16 years old. Oral drugs denote medicine consumed orally, usually in the form of tablets, capsules, or liquid solutions. As an illustration, in February 2024, Biogen Inc., an American biotech firm, declared that the European Commission (EC) gave their approval for SKYCLARYS (omaveloxolone) to be used in the treatment of Friedreich's ataxia (FA). SKYCLARYS functions by activating the Nrf2 pathway to manage the core issues of oxidative stress and mitochondrial dysfunction in Friedreich's ataxia. The drug is consumable orally without needing food and has exhibited an improvement in symptoms while slowing down the illness advancement in clinical research. However, it can cause side effects such as elevated liver enzymes, headaches, nausea, stomach pain, tiredness, diarrhea, and musculoskeletal discomfort.
How Is the Segmentation of the Progressive Ataxia And Weakness Disorders Market Defined?
The progressive ataxia and weakness disorders market covered in this report is segmented -
1) By Type: Progressive Ataxia, Progressive Weakness Disorders
2) By Technology: Small Molecule, Monoclonal Antibody, Other Technology
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy
4) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Progressive Ataxia: Cerebellar Ataxia, Sensory Ataxia, Vestibular Ataxia, Friedreich's Ataxia, Spinocerebellar Ataxia (SCA), Idiopathic Ataxia
2) By Progressive Weakness Disorders: Amyotrophic Lateral Sclerosis (ALS), Muscular Dystrophy, Spinal Muscular Atrophy (SMA), Myasthenia Gravis, Multiple Sclerosis (MS), Guillain-Barré Syndrome (GBS)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/progressive-ataxia-and-weakness-disorders-global-market-report
What Is the Leading Region in the Progressive Ataxia And Weakness Disorders Market?
North America was the largest region in the progressive ataxia and weakness disorders market in 2023. The regions covered in the progressive ataxia and weakness disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Progressive Ataxia And Weakness Disorders Global Market Report?
- Market Size Analysis: Analyze the Progressive Ataxia And Weakness Disorders Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Progressive Ataxia And Weakness Disorders Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Progressive Ataxia And Weakness Disorders Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Progressive Ataxia And Weakness Disorders Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18444
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Progressive Ataxia And Weakness Disorders Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3863889 • Views: …
More Releases from The Business Research Company
Ergonomic Office Chairs Market Size Forecast: $17.84 Billion by 2029 | Global Ou …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Ergonomic Office Chairs Market by 2025?
The market size of ergonomic office chairs has experienced constant growth over the past few years. The market worth is anticipated to rise from $13.81 billion in 2024 to $14.49 billion in 2025, presenting a compound…
Carbon Composites Market Growth to be Driven by Emerging Trends | $28.25 Billion …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Carbon Composites Industry?
In the recent past, the carbon composites market has witnessed a significant expansion in its size. The market, worth $20.57 billion in 2024, is projected to rise to $21.71 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Acrylic Surface Coating Industry Growth Outlook: 7.1% CAGR and $40.66 Billion by …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Acrylic Surface Coating Market Size 2025?
In recent times, there has been a substantial uptick in the growth of the acrylic surface coating market. The market is projected to expand from $29.11 billion in 2024 to $30.87 billion in 2025, showcasing a Compound Annual…
Global UV Inkjet Printing Market Expansion at 9.4% CAGR, Valued at $86.05 Billio …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the UV Inkjet Printing Market Size Forecast for 2025?
The market for UV inkjet printing has experienced substantial growth in recent years, with its value set to increase from $54.85 billion in 2024 to $60.09 billion in 2025. This translates to a compound annual growth rate (CAGR) of…
More Releases for Ataxia
Friedreich's Ataxia Market Detailed Industry Report Analysis 2025-2034
Introduction
Friedreich's ataxia (FA) is a rare and hereditary neurodegenerative disorder characterized by progressive loss of coordination and neurological function, often accompanied by cardiomyopathy and other complications. For decades, treatments have focused only on symptom management. Recently, gene therapies, novel pharmacological candidates, and targeted diagnostics are transforming the landscape, supported by increased patient advocacy and rare disease funding.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71063
Market Overview
• Market Size (2024): USD…
Key Trends Reshaping the Progressive Ataxia And Weakness Disorders Market: Innov …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Progressive Ataxia And Weakness Disorders Market Size Growth Forecast: What to Expect by 2025?
The market size for progressive ataxia and weakness disorders has seen a swift expansion in the past few years. It is projected to escalate from $34.72 billion in 2024 to $38.67 billion in 2025, boasting…
Ataxia Pipeline: Advancing Therapeutics and 32+ Leading Companies Shaping the At …
The therapeutic landscape for Ataxia, a group of rare neurological disorders characterized by impaired coordination and balance, is witnessing significant momentum, driven by advances in genetic research, biomarker development, and a surge in innovative therapies. Biopharmaceutical companies such as Retrotope, Reata Pharmaceuticals, PTC Therapeutics, Metro International Biotech, LLC, and Design Therapeutics are leading the charge, targeting key pathways like mitochondrial dysfunction, cerebellar degeneration, and RNA-based mechanisms to develop disease-modifying treatments…
Prominent Ataxia Market Trend for 2025: Revolutionizing Ataxia Treatment With Gr …
What industry-specific factors are fueling the growth of the ataxia market?
The increasing rate of alcohol intake is projected to stimulate the expansion of the ataxia market in the future. Alcohol consumption typically involves the oral ingestion of an ethanol-containing drink. Chronic misuse of alcohol primarily causes cerebellar degeneration, a common type of acquired toxic ataxia. Those suffering from alcoholism often manifest lower limb postural tremors and gait ataxia. For example,…
Spinocerebellar Ataxia Market Analysis: Opportunities & Forecast 2024-2031
Spinocerebellar Ataxia Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an…
Fighting Ataxia: Market Report 2024 Spotlights Treatment Advancements
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Ataxia Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $51.3 billion In 2028 At A…
